About Penta
Who we are
Diversity and Inclusion
Penta ID Network
Penta Foundation Italy
Penta Foundation UK
Penta ID Innovation
Annual reports
Our Activities
News & Events
News
Press center
Penta Newsletter
Stories
Scientific Views
Penta Aperitivo Webinars
Publications
Contact us
Work with us
Vacancies
Call for services
Diversity & Inclusion
Brighter Future Award
Archivio
Venetonight 2018 – The European Researchers’ Night
UNICEF report – “Women: At the heart of the HIV response for children”
c4c National Hubs Meeting, Paris: enthusiasm, synergy, engagement!
Steady-state pharmacokinetics and early safety data in HIV-infected African children weighing ≥25kg after switching to 50mg film-coated dolutegravir tablets in the ODYSSEY trial
World Sepsis Day – 13th Sept. 2018
EFGCP/DIA Paediatrics Conference: Better Medicines for Children – From Development to Access
Seroprevalence of dengue, chikungunya and Zika viruses in an antenatal population in the greater Kingston metropolitan region of Jamaica
Investigating vertical transmission of chikungunya, dengue and zika virus infection: a prospective observational cohort study of pregnant women and infants in Jamaica
NeoVanc: Over 50% of patients now enrolled!
Evidence for mother-to-child transmission of Zika virus through breast milk
EMA: Fostering medicines for children
Time of ART initiation in perinatally HIV-infected children impacts on HIV-specific T cell functionality
Time to viral rebound after stopping art in children treated from infancy in cher
Lasting immune impacts of age at start of ART in vertically HIV-infected adolescents
Factors associated with HIV DNA levels in children starting antiretroviral therapy (ART) early in infancy